Satavaptan Dose-Ranging Study in Normonatraemic Patients With Cirrhotic Ascites

Mise à jour : Il y a 4 ans
Référence : NCT00501566

Femme et Homme

Extrait

The primary objective is to determine the optimal dose or range of doses of SR121463B for the treatment of ascites when used concomitantly with a standard dose regimen of spironolactone and furosemide. The secondary objective is to determine the tolerability of different fixed doses of SR121463B over a 14 day treatment period in cirrhotic ascites.


Critère d'inclusion

  • Ascites ,Liver cirrhosis


Liens